Mycophenolate mofetil Active Not Recruiting Phase 2 Trials for Myelodysplastic Syndromes / Agnogenic Myeloid Metaplasia / Smith-Magenis Syndrome / Refractory Anemia / Acute Lymphocytic Leukemia (ALL) / Leukemia, Prolymphocytic / Multiple Myeloma (MM) / Non-Hodgkin's Lymphoma (NHL) / Leukemias / chronic Chronic myelogenous leukemia / Leukemia Acute Myeloid Leukemia (AML) / Chronic Lymphocytic Leukaemia (CLL) / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00309842Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
NCT00882895Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
NCT00534430Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
NCT01252667Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant
NCT02441803Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
NCT00041288Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
NCT00574496Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma